Skip to content
Disclosery

Ilex Capital Partners (UK) LLP: BIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Ilex Capital Partners (UK) LLP on BIO, newest first. How the timeline and the estimate are built.

Ilex Capital Partners (UK) LLP held 0 BIO shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -100,558 shares

    13F-HR 0001172661-26-000930 filed by Ilex Capital Partners (UK) LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 100,558 shares
    Change vs previous 13F -20,327 shares

    0.9% of the 13F portfolio, value $28,195,458.

    13F-HR 0001172661-25-005016 filed by Ilex Capital Partners (UK) LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 120,885 shares
    Change vs previous 13F +114,490 shares

    0.97% of the 13F portfolio, value $29,171,968.

    13F-HR 0001172661-25-003377 filed by Ilex Capital Partners (UK) LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 6,395 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $1,557,566.

    13F-HR 0001172661-25-002303 filed by Ilex Capital Partners (UK) LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).